IRIS
COLOMBO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.476
EU - Europa 3.861
NA - Nord America 3.572
SA - Sud America 1.238
Continente sconosciuto - Info sul continente non disponibili 302
AF - Africa 85
OC - Oceania 1
Totale 13.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.371
RU - Federazione Russa 2.392
SG - Singapore 1.775
CN - Cina 1.265
BR - Brasile 997
HK - Hong Kong 541
SE - Svezia 526
VN - Vietnam 438
IT - Italia 339
FR - Francia 211
BD - Bangladesh 125
DE - Germania 113
AR - Argentina 89
GB - Regno Unito 89
CA - Canada 86
IN - India 68
EC - Ecuador 48
MX - Messico 47
ID - Indonesia 40
FI - Finlandia 31
TR - Turchia 29
IQ - Iraq 28
CO - Colombia 27
JP - Giappone 27
PY - Paraguay 27
IE - Irlanda 26
PL - Polonia 23
ZA - Sudafrica 21
AT - Austria 20
NL - Olanda 19
UZ - Uzbekistan 19
ES - Italia 18
JM - Giamaica 16
PE - Perù 15
LT - Lituania 14
PK - Pakistan 14
UA - Ucraina 13
CL - Cile 12
SA - Arabia Saudita 12
MA - Marocco 11
MY - Malesia 11
TN - Tunisia 11
VE - Venezuela 11
IR - Iran 10
EG - Egitto 9
AE - Emirati Arabi Uniti 8
BB - Barbados 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
HN - Honduras 7
JO - Giordania 7
NP - Nepal 7
PH - Filippine 7
UY - Uruguay 7
GT - Guatemala 6
KE - Kenya 6
AZ - Azerbaigian 5
ET - Etiopia 5
IL - Israele 5
OM - Oman 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EU - Europa 4
KW - Kuwait 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
BH - Bahrain 3
KZ - Kazakistan 3
LY - Libia 3
MD - Moldavia 3
PR - Porto Rico 3
SC - Seychelles 3
AM - Armenia 2
BM - Bermuda 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
GY - Guiana 2
LK - Sri Lanka 2
MK - Macedonia 2
QA - Qatar 2
SN - Senegal 2
SR - Suriname 2
SV - El Salvador 2
TH - Thailandia 2
VC - Saint Vincent e Grenadine 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
Totale 13.221
Salva come PNG Salva come JPEG
Città #
Dallas 714
Singapore 695
Moscow 555
Hong Kong 532
San Jose 369
Ashburn 350
Shanghai 293
Council Bluffs 232
Hefei 212
Princeton 192
Lawrence 191
Lauterbourg 181
Ho Chi Minh City 154
New York 124
Beijing 116
Hanoi 97
Milan 89
São Paulo 84
Santa Clara 75
Los Angeles 61
Rome 37
Orem 32
Da Nang 31
Boardman 29
Brooklyn 29
Brasília 26
Nuremberg 26
Dublin 25
Belo Horizonte 24
Chennai 24
Haiphong 24
Helsinki 24
Rio de Janeiro 23
Phoenix 21
Houston 20
London 20
Munich 20
Brescia 19
Guangzhou 19
Chicago 18
Denver 18
Quito 18
Tashkent 18
Warsaw 18
Mexico City 17
Montreal 16
Porto Alegre 16
Tokyo 16
Atlanta 15
Johannesburg 15
Salvador 15
Biên Hòa 14
Boston 14
Frankfurt am Main 14
Guayaquil 14
Hangzhou 14
The Dalles 13
Curitiba 12
Manchester 12
Mumbai 12
Toronto 12
Bogotá 10
Changsha 10
Naples 10
Sorocaba 10
Stockholm 10
Ankara 9
Campinas 9
Fortaleza 9
Guarulhos 9
Lima 9
Poplar 9
São Bernardo do Campo 9
Buenos Aires 8
Charlotte 8
Columbus 8
Dhaka 8
Hải Dương 8
Istanbul 8
Kuala Lumpur 8
Las Vegas 8
Recife 8
Uberlândia 8
Vienna 8
Amsterdam 7
Buffalo 7
Catania 7
Durham 7
Erbil 7
Goiânia 7
San Francisco 7
São Gonçalo 7
Vancouver 7
Amman 6
Assago 6
Bari 6
Bologna 6
Bridgetown 6
Cabo Frio 6
Calgary 6
Totale 6.426
Salva come PNG Salva come JPEG
Nome #
Prognostic impact of mitral regurgitation changes after TAVI 228
Impact on Outcome of Different Mechanisms, Baseline Degree and Changes of Mitral Regurgitation in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement 150
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 149
[New therapeutic options for the treatment of tricuspid regurgitation] 146
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 139
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 135
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 131
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 119
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study) 118
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 114
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 112
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 108
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 108
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 108
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 106
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 105
Diabetes and mortality in patients with COVID-19: Are we missing the link? 104
Right ventricular systolic function in severe tricuspid regurgitation: prognostic relevance of longitudinal strain 103
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 101
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 99
A new tool for the forgotten valve: a score to predict the risk of surgery 97
The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification 97
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 96
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 96
[40 Years of coronary angioplasty: success comes from skills and determination!] 95
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 94
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 92
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels 92
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Through Ipsilateral Collateral Channels: A Multicenter Registry 92
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 91
CT-scan theoretical analysis for aortic cross-clamp and opening after transcatheter aortic valve implantation 91
Impact of Left Main Calcium With Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Left Main Narrowings (from the Milan and New-Tokyo Registry) 89
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 89
Role of Different Antithrombotic Regimens after Percutaneous Left Atrial Appendage Occlusion: A Large Single Center Experience 89
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 86
Bioresorbable Vascular Scaffolds for the Treatment of Chronic Total Occlusions: An International Multicenter Registry 83
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 82
Advances in percutaneous interventional therapies: The tricuspid valve 81
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 79
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 79
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 79
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 77
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 77
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 76
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 76
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 76
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 76
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 74
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 74
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 74
Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study 74
Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry 73
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis 73
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 73
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 73
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 71
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 71
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. 70
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 69
Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry 69
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 67
Meta-Analysis of Relation Between Left Ventricular Dysfunction and Outcomes After Transcatheter Mitral Edge-to-Edge Repair 66
Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning 65
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 64
First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries 64
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 64
Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions 63
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 63
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 63
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?: A Meta-Analysis of Randomized Controlled Trials 63
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 63
Coronary Access After Repeated Transcatheter Aortic Valve Implantation: A Glimpse Into the Future 63
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 63
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 63
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 62
Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis 62
Dual antiplatelet therapy after drug-eluting stents. How long to treat? 61
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 61
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients 61
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory? 61
Clinical Significance of Intravascular Ultrasound-Detected Vascular Injury Following Chronic Total Occlusion Recanalization With Intraplaque Versus Subintimal Tracking Techniques 61
Coronary Sinus Reducer Implantation to Reduce the Ischemic Burden in Refractory Angina 61
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting 61
Implementation of a Low Frame-Rate Protocol and Noise-Reduction Technology to Minimize Radiation Dose in Transcatheter Aortic Valve Replacement 60
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 60
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock 60
Subclinical Leaflet Thrombosis After Transcatheter Mitral Valve-in-Ring Implantation 60
Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction 60
Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type 59
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 59
Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution 59
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions 59
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 59
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 59
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 58
Procedural and Long-Term Outcomes of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion 58
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 58
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 57
Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study 57
Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study 57
Totale 8.192
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.370
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202294 0 0 0 40 2 4 5 4 8 0 7 24
2022/2023994 408 225 87 7 6 108 30 54 29 6 15 19
2023/2024444 19 32 53 59 37 50 13 41 5 10 21 104
2024/20252.582 386 23 16 59 63 209 361 186 452 293 257 277
2025/20268.381 503 786 919 1.288 581 188 680 491 2.147 356 224 218
2026/2027804 309 495 0 0 0 0 0 0 0 0 0 0
Totale 13.535